4//SEC Filing
Collins Cooper C. 4
Accession 0000905148-24-002363
CIK 0000025743other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 5:40 PM ET
Size
4.9 KB
Accession
0000905148-24-002363
Insider Transaction Report
Form 4
Collins Cooper C.
Director
Transactions
- Purchase
Common Stock
2024-08-22$1.73/sh+4,094$7,099→ 52,016 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $1.69 through $1.75, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001485508
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 5:40 PM ET
- Size
- 4.9 KB